Comparison
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 vs 46 Xx Gonadal Dysgenesis C0685837
Clinical comparison between 46 XY Disorder OF Sex Development Due TO Testicular 17 20 Desmolase Deficiency and 46 XX Gonadal Dysgenesis for differential diagnosis and treatment planning.
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
A rare genetic condition where the testes cannot make enough testosterone due to an enzyme deficiency. This affects genital development and puberty. Treatment includes hormone therapy and may involve surgery.
46 Xx Gonadal Dysgenesis C0685837
A condition affecting ovarian development in individuals with two X chromosomes. May impact puberty and fertility. Treatment typically includes hormone replacement and supportive care.
6 comparison axes
Onset
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
0-16
46 Xx Gonadal Dysgenesis C0685837
12-16
Onset patterns differ
Severity
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
severe
46 Xx Gonadal Dysgenesis C0685837
moderate
Different severity levels
Chronic
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
Chronic
46 Xx Gonadal Dysgenesis C0685837
Chronic
Differing course
Communicable
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
No
46 Xx Gonadal Dysgenesis C0685837
No
Different transmission
Body System
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
reproductive
46 Xx Gonadal Dysgenesis C0685837
reproductive
Same/different system
Category
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
endocrine
46 Xx Gonadal Dysgenesis C0685837
genetic
Different category
Bottom line
46-xy-disorder-of-sex-development-due-to-testicular-17-20-desmolase-deficiency-C1839840 and 46-xx-gonadal-dysgenesis-C0685837 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 | 46 Xx Gonadal Dysgenesis C0685837 | Discriminating power |
|---|---|---|---|
| Genital development | May show undervirilization or atypical genitalia from insufficient testicular testosterone. | Typical female external genitalia are often expected, but this is not definitive. | Moderate |
| Puberty | Pubertal androgen effects may be reduced or delayed. | Puberty may be absent or incomplete because ovarian function is impaired. | Moderate |
| Fertility potential | Fertility may be affected, but individual potential is not established by these data. | Ovarian dysgenesis commonly threatens spontaneous fertility; confirmation is required. | Low |
When to favor each condition
Choose 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 when
46,XY karyotype with suspected testicular steroid-enzyme defect
The supplied mechanism specifically concerns impaired testicular testosterone synthesis.
High
Atypical genital development beginning in childhood
The source places onset from birth through adolescence and links it to genital development.
Moderate
Need to explain androgen deficiency rather than absent ovaries
The core distinction is enzyme-related testicular hormone production, not ovarian dysgenesis.
High
Choose 46 Xx Gonadal Dysgenesis C0685837 when
46,XX karyotype with impaired ovarian development
The diagnosis is defined by two X chromosomes and abnormal gonadal development.
High
Pubertal delay or amenorrhea around ages 12–16
The supplied onset is concentrated in early-to-mid adolescence.
Moderate
Supportive care focused on ovarian insufficiency
The source emphasizes hormone replacement and supportive management rather than testicular enzyme deficiency.
Moderate
How key tests differ
| Test | 46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840 | 46 Xx Gonadal Dysgenesis C0685837 | Interpretation |
|---|---|---|---|
| Karyotype | 46,XY is expected if the named condition is confirmed. | 46,XX is expected if the named condition is confirmed. | Karyotype is a major discriminator, but diagnosis requires full clinical correlation. |
| Gonadal assessment | Testicular tissue is implicated, with impaired hormone production. | Ovarian development is abnormal; streak or dysgenetic gonads may be found. | Imaging or histology must be interpreted by specialists; appearance alone is not diagnostic. |
| Sex-steroid evaluation | A pattern suggesting reduced testicular androgen synthesis may be sought. | Findings may suggest impaired ovarian hormone production. | No exact cutoff is supplied; abnormal results are not themselves a complete diagnosis. |
Prognosis comparison
46 Xy Disorder Of Sex Development Due To Testicular 17 20 Desmolase Deficiency C1839840
- Outcome
- Chronic condition; long-term outcome is variable and not quantified here.
- Factors
- Genital development, hormone response, and individualized treatment decisions.
46 Xx Gonadal Dysgenesis C0685837
- Outcome
- Chronic ovarian insufficiency pattern is possible; exact prognosis is not established.
- Factors
- Degree of gonadal function, puberty, fertility goals, and supportive care.
Time frame: From childhood or adolescence into adult follow-up.
Karyotype confirmation, hormone findings, associated anomalies, and patient priorities.
Complications comparison
| Complication | Presentation |
|---|---|
| Pubertal disruption | Reduced androgen-dependent development may occur. Absent or incomplete ovarian-driven puberty may occur. Timing and severity vary; clinician assessment is required. |
| Fertility impairment | Possible but not quantified by the supplied evidence. A recognized concern with gonadal dysgenesis, though individual outcome varies. Do not infer a specific fertility prognosis without specialist evaluation. |
| Psychosocial burden | Genital differences and treatment decisions may cause distress. Delayed puberty and fertility concerns may affect wellbeing. Support should be individualized; no comparative rate is established. |
Patient education highlights
- HighDiagnosis versus test result
An abnormal karyotype or hormone result supports evaluation but does not alone establish either diagnosis.
- HighSpecialist care
Endocrine, genetics, and reproductive specialists should interpret results and discuss options.
- MediumTreatment boundaries
Hormone therapy or surgery may be considered, but doses and procedures are not specified here.